Question 60 (part 2) · LEK · Treatment
Which of the statements below is true about metformin:
- A. it must not be used in obese patients with diabetes type 1.
- B. it is the first-line treatment in diabetes types 2, regardless of the patient’s body mass.
- C. it should be discontinued when the glomerular filtration rate is 30-45 ml/min/1,73 m2.
- D. it might increase the risk of ketoacidosis.
- E. its main side effect is constipation.
Hint
Think about the drug's place in type 2 diabetes algorithms and its eGFR thresholds for dose reduction versus withdrawal.
The answer, the explanation and a note on every option are available once you log in. The account is free: topic tests, a mock exam, mistake review and statistics.
More questions on Internal medicine
- The symptoms of hypercalcaemia include:
- The vascular pulmonary reactivity test used in the diagnosis of pulmonary hypertension might be performed with the use of the drugs given below…
- Which of the following is a monoclonal antibody that is used in the treatment of cancer (Non-Hodgkin lymphoma, chronic lymphocytic leukaemia, acute…
- Which is a biomarker of significant use in the diagnosis and monitoring of somatotrophic pituitary adenomas?
- Which is a biological drug used in the treatment of autoimmune diseases (including rheumatoid arthritis) that prevents the second signal in the…
- The list below includes selected diagnostic factors or symptoms that allow the diagnosis and assessment of the activity of rheumatoid arthritis…